NUTR NUTR
Company Profile ↓Company Overview
NUTR (NUTR) is a publicly traded company listed on with a market capitalization of $169.35M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 19.7%, reflecting efficient use of shareholder capital.
Carries low leverage with a debt-to-equity ratio of 0.02.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2024 Revenue of $1.18M (-48.8% YoY); net profit $-779.23K.
- Trailing 12 Months Year-on-year growth — revenue -48.8%, earnings -1085.0%.
- 5-Year Trend Long-term compounding — revenue CAGR -8.3%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -8.26% |
| 1 Year: | -48.79% |
Compounded Profit Growth
| 5 Years: | - |
| 1 Year: | -1,084.95% |
Stock Price Performance
| 1 Year: | +130.18% |
| 6 Months: | +0.00% |
| 3 Months: | +0.00% |
| 1 Month: | +0.00% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)79.94 · Overbought
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Generates positive free cash flow.
CONS
- Revenue declined at -8.3% CAGR over 5 years.
- RSI at 80 suggests overbought conditions.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|
| Revenue | 173.50K | 173.45K | 294.04K | 283.16K | 993.04K | 768.67K |
| Cost of Revenue | - | - | 1.30K | 0 | 0 | 0 |
| Gross Profit | 169.36K | 169.17K | 292.74K | 283.16K | 993.04K | 768.67K |
| Operating Expenses | - | - | 517.89K | 839.41K | 584.34K | 2.02M |
| Operating Income | -413.61K | -73.09K | -225.16K | -556.26K | 408.70K | -1.25M |
| EBITDA | - | - | -285.38K | -525.11K | 1.01M | -985.95K |
| Interest Expense | - | - | 26 | 63 | 0 | 0 |
| Pretax Income | - | - | -307.07K | -540.31K | 997.69K | -1.00M |
| Tax Provision | - | - | -7.93K | 0 | 0 | 47.84K |
| Net Income | -432.25K | -43.03K | -296.15K | -536.22K | 920.33K | -963.69K |
| Diluted EPS | -0.36 | -0.01 | - | -0.03 | 0.05 | -0.17 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 |
|---|---|---|---|
| Revenue | 1.40M | 2.31M | 1.18M |
| Cost of Revenue | 1.34K | 42.53K | 17.77K |
| Gross Profit | 1.40M | 2.27M | 1.16M |
| Operating Expenses | 3.33M | 2.33M | 1.91M |
| Operating Income | -1.93M | -65.43K | -744.73K |
| EBITDA | -754.59K | 211.46K | -686.02K |
| Interest Expense | 0 | 841 | 26 |
| Pretax Income | -838.80K | 96.10K | -791.13K |
| Tax Provision | 179.12K | 16.18K | -4.03K |
| Net Income | -763.44K | 79.11K | -779.23K |
| Diluted EPS | -0.04 | 0.00 | -0.04 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 |
|---|---|---|---|
| Total Assets | 4.09M | 3.78M | 11.37M |
| Current Assets | 3.43M | 3.11M | 11.07M |
| Cash & Equivalents | 1.76M | 575.45K | 6.93M |
| Inventory | 825 | 309.38K | 77.49K |
| Receivables | 534.95K | 382.76K | 208.41K |
| Total Liabilities | 9.07M | 9.06M | 17.20M |
| Current Liabilities | 8.64M | 8.75M | 17.07M |
| Long Term Debt | - | - | - |
| Total Debt | 302.10K | 244.07K | 116.42K |
| Total Equity | -3.14M | -3.42M | -3.96M |
| Shares Outstanding | 18.82M | 18.82M | 18.82M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 |
|---|---|---|---|
| Operating Cash Flow | 885.72K | -919.56K | 6.37M |
| Investing Cash Flow | -226.74K | -29.55K | -29.96K |
| Financing Cash Flow | - | - | - |
| Capital Expenditure | -226.74K | -29.55K | -29.96K |
| Free Cash Flow | 658.98K | -949.11K | 6.34M |
| Net Change in Cash | 658.98K | -949.11K | 6.34M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 |
|---|---|---|---|
| Gross Margin % | 99.9% | 98.2% | 98.5% |
| Operating Margin % | -137.5% | -2.8% | -63.0% |
| Net Margin % | -54.4% | 3.4% | -65.9% |
| ROE % | 24.3% | -2.3% | 19.7% |
| ROCE % | 42.5% | 1.3% | 13.1% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for NUTR
NUTR | Nusatrip Incorporated Common Stock Insider Trading - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTE5yOVBJRkJlOW85cDRxQW16V3htc2Joa2JZSDNhaEJhUEdNcmtvMV8zWHJYLTl4OTJzNXo0VmdyRXFGVFpQQXYyVjZqakduRXd0a2hGRkRoYXVaOS1P?oc=5" target="_blank">NUTR | Nusatrip Incorporated Common Stock I…
NusaTrip Shares Will Stay Halted Until Any Appeal Is Resolved - Stock Titan
<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxNWkdKN2hpM3h0emNhQmJCUEVfV2lrWjBmc2pnNnR1clRMNi1ndV9JU082TjVnSFdIOG9tWnFBWWdYMjkyWWVkRVJORUQ3R0l0Tnp3X2lhemtmc245aG5BRVd6Mm5HSzltWDVsUVpqblJaaElTMEZoMEdUMHlrUmdlVTV5VF9maUJUeGt4Sz…
NusaTrip Incorporated Notified of Anticipated Delisting From The Nasdaq Stock Market - Moomoo
<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxPc2JHN08tcXFsb1dacHZCZ0dzUUZMZDdIaHJMQWtWRmFrLVRfZE1QQ2VzTmJLQmVMbEM0cEFVak5qVVgzWG92dXlKeGRHWUF4RGw3RXBrSGJDa0pOa21yMVh4UHlFTzdoejlpWTN5YlhVQ1Q4TVJjdGJZd0h6V3lFWllqOW5KTEZSODQzdT…
NusaTrip Incorporated Notified of Anticipated Delisting from The Nasdaq Stock Market - The Manila Times
<a href="https://news.google.com/rss/articles/CBMi7wFBVV95cUxPcW02VkwyLVZIVXBEdXlnUE1CZmdibVJfZTQyTVNicGV1Qzg3djlzTUVHUzZCN0ZZbnpmZkgyeWRLUGxYeWV2VDk2bkdjRTZTY3ZiQjhYb3A1UGRNT2tsSk82ZXM2dm93U0trRUF4TjU0eGlZcUVhc1VTV1Bkc1dsUDdFeG1IR0NJTENMWU…
NusaTrip receives Nasdaq delisting notice for filing delays - Investing.com
<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxOcS1faTUwNzJsaElSam5CdHJEQ3VQcUt5YWduUUJOUTNtT0RFeko4aG0yZ3kwQk5tY3p2cGtVZUtlWVI3bW43OGwtOE9mOXhGdDJJYnRGelV6MnRJSzk5SDNJRnpiUEFMcndkWk00cVdQR0J6T3hPSXJWLTVjY3ZGMEI5RDRzb3JRZGhEbG…
Nutrition Requirements in Medical Training Are Expanding: Here's What the Industry Should Know - Nutritional Outlook
<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxNbFZjc3prUnZPeC1lX25wU0lMQkd4dUtkVm1RRmtDb2wxa21CZm8zbGZlVjFQQV96cnhzSTlBYU1sQ25fMUxTV2tmcS13Sk9DZzFuYVpwNUdGMXF3MXlZWjVkU0lCOGNsZ0doWVdlTWhya3RzQ2xHOUg5YUhrRUUxZlNfTWEzNzVtVmVXcz…
NUTR — Frequently Asked Questions
What is the current share price of NUTR?
As of 2026-08-05 17:25 PDT, NUTR trades at $9.00 on NASDAQ/NYSE. Its 52-week range is $3.91 to $9.30.
What is the market capitalisation of NUTR?
NUTR has a market capitalisation of $169.35M on NASDAQ/NYSE.
What is the P/E ratio of NUTR?
NUTR trades at a trailing price-to-earnings (P/E) ratio of -217.33. Its price-to-book (P/B) ratio is -42.78.
What is the return on equity (ROE) of NUTR?
NUTR has a return on equity (ROE) of 19.68%. Its return on capital employed (ROCE) is 13.05%.
Is NUTR a good stock to buy?
This page provides a data-driven analysis of NUTR, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.